Telomir Pharmaceuticals, Inc. (TELO) Operating cash flow 2022–2025
Telomir Pharmaceuticals, Inc. (TELO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$3.7MFY2025 · since FY2022: -$468,661 → -$3.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.7M | +27.3% |
| FY2024 | -$5.1M | -31.4% |
| FY2023 | -$3.9M | -723.6% |
| FY2022 | -$468,661 | — |
Source: SEC XBRL filings · For reference only · Not investment advice